- ►annals.org [PDF] S Grabar, VL Moing, C Goujard, C Leport, MD … - Annals of internal medicine, 2000 - Am Coll Physicians Clinical Outcome of Patients with HIV-1 Infection according to ... Immunologic
and Virologic Response after 6 Months of Highly Active ... Sophie Grabar, MD,
MPH; Vincent Le Moing, MD, MPH; Cécile Goujard, MD; Catherine Leport, MD, ... Cited by 275 - Related articles - BL Direct - All 5 versions
C Piketty, L Weiss, F Thomas, AS Mohamed, … - The Journal of infectious diseases, 2001 - UChicago Press Featured in Grist "Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the
Control of Avian and Swine Influenzas Eileen Thacker and Bruce Janke Read ... Cited by 98 - Related articles - BL Direct - All 5 versions
SG Deeks, JD Barbour, RM Grant, JN Martin - Aids, 2002 - journals.lww.com Skip Navigation Links Home > January 25, 2002 - Volume 16 - Issue 2 > Duration
and predictors of CD4 T-cell gains in patients who... ... Deeks, Steven G.;
Barbour, Jason D.; Grant, Robert M.; Martin, Jeffrey N. Cited by 136 - Related articles - BL Direct - All 6 versions
C Piketty, P Castiel, L Belec, D Batisse, AS … - Aids, 1998 - journals.lww.com Piketty, Christophe; Castiel, Philippe; Belec, Laurent; Batisse, Dominique;
Mohamed, Ali Si; Gilquin, Jacques; Gonzalez-Canali, Gustavo; Jayle, Didier;
Karmochkine, Marina; Weiss, Laurence; Aboulker, Jean Pierre; Kazatchkine, ... Cited by 158 - Related articles - BL Direct - All 4 versions
SG Deeks, JD Barbour, JN Martin, MS … - The Journal of infectious diseases, 2000 - UChicago Press Featured in US News & World Report "Common Cold Virus Alters Body's Genes"
October 24, 2008 Comparison of the Safety and Immunogenicity of 2 Respiratory
Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine ... Cited by 250 - Related articles - BL Direct - All 5 versions
D Kaufmann, G Pantaleo, P Sudre, A Telenti … - Lancet, 1998 - hawaii.edu We followed all 101 individuals at an HIV-1 outpatient unit who started HAART
before February, 1997, and received treatment for at least the first 3 months.
All the patients had extensive exposure to antiretrovirals and had ... Cited by 282 - Related articles - View as HTML - BL Direct - All 4 versions
- ►itg.be [PDF] E Florence, J Lundgren, C Dreezen, M Fisher, O … - Name: HIV Medicine, 2003 - dspace.itg.be Page 1. Factors associated with a reduced CD4+ lymphocyte count response to
HAART despite full viral suppression in the EuroSIDA study ... Cited by 58 - Related articles - View as HTML - BL Direct - All 7 versions
- ►aafhospitalaria.org.ar [PDF] DM Moore, RS Hogg, B Yip, E Wood, M Tyndall … - JAIDS Journal of Acquired Immune Deficiency …, 2005 - journals.lww.com David M. Moore, MDCM, MHSc, FRCPC,* Robert S. Hogg, PhD,*† Benita Yip, BSc
(Pharm),* Evan Wood, PhD,*‡ Mark Tyndall, MD, FRCPC, ScD,*‡ Paula
Braitstein, PhD,*§ and Julio SG Montaner, MD, FRCPC*‡ Cited by 53 - Related articles - BL Direct - All 10 versions
L Weiss, M Kazatchkine - Annales de l'Institut Pasteur-Actualites, 2000 - Elsevier Le succès immunologique, caractérisé par une reconstitution du pool de
lymphocytes T CD4 au cours des traitements antirétroviraux « hautement
actifsest directement associé à un succès clinique. L'introduction des ... Related articles - All 2 versions
- ►infekt.ch [PDF] B Ledergerber, M Egger, M Opravil, A Telenti, … - The Lancet, 1999 - Elsevier An estimated 90·7% of treatment-naïve patients reached undetectable viral load
(<400 copies/mL) by 12 months. Among pretreated patients, estimates ranged from
70·3% treated with one new drug to 78·7% on three new drugs. 2 years ... Cited by 745 - Related articles - All 6 versions
